Summary by Moomoo AI
Arcutis Biotherapeutics, Inc. (ARQT) reported that its Chief Financial Officer, John W Smither, acquired a total of 11,365 shares of common stock on February 13, 2024. The transactions were classified as 'A' for acquisition under the transaction code, indicating they were likely grants or awards. Following these acquisitions, Smither directly holds 11,365 shares. Additionally, it was disclosed that Smither indirectly holds 141,392 shares of Arcutis Biotherapeutics common stock through a trust.